Positions

Overview

  • Dr. Ghazi is an Assistant Professor of Epidemiology at the University of Alabama at Birmingham. She obtained her MD from the American University of Beirut Lebanon and her PhD in Epidemiology with a minor in population studies from the University of Minnesota. She then completed a postdoctoral fellowship at the Clinical and Translational Accelerator at Yale University. Her research interests lie at the intersection of chronic disease prevention, specifically hypertension and chronic kidney disease, health disparities, and digital health by leveraging real world data and using implementation science methods to transform chronic disease prevention and management.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2022 Rationale and design of a pragmatic trial aimed at improving treatment of hyperlipidemia in outpatients with very high risk atherosclerotic cardiovascular disease: A pragmatic trial of messaging to providers about treatment of hyperlipidemia (PROMPT-LIPID)American Heart Journal.  253:76-85. 2022
    2022 A Clinical Framework for Evaluating Machine Learning StudiesJACC: Heart Failure.  10:648-650. 2022
    2022 Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized with Heart Failure: The REVEAL-HF Randomized Clinical TrialJAMA Cardiology.  7:905-912. 2022
    2022 Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data from the Systolic Blood Pressure Intervention Trial (SPRINT)JAMA Network Open.  5:E2220680. 2022
    2022 The association between fine particulate matter (PM2.5) and chronic kidney disease using electronic health record data in urban MinnesotaJournal of Exposure Science and Environmental Epidemiology.  32:583-589. 2022
    2022 Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized TrialJournal of the American College of Cardiology.  79:2203-2213. 2022
    2022 Excessive Blood Pressure Response to Clonidine in Hospitalized Patients With Asymptomatic Severe HypertensionAmerican Journal of Hypertension.  35:433-440. 2022
    2022 Prevalence of Secondary Hypertension in Otherwise Healthy Youths with a New Diagnosis of Hypertension: A Meta-AnalysisJournal of Pediatrics.  244:30-37.e10. 2022
    2022 Screening for Hypertension in Children with and Without Autism Spectrum DisorderJAMA Network Open.  5. 2022
    2022 Blood pressure response to commonly administered antihypertensives for severe inpatient hypertensionPLoS One.  17. 2022
    2022 Severe inpatient hypertension prevalence and blood pressure response to antihypertensive treatmentJournal of Clinical Hypertension.  24:339-349. 2022
    2022 Kidney Function Decline in Young Adulthood and Subsequent 24-Hour Ambulatory Blood Pressure in Midlife: The CARDIA Study 2022
    2022 Rationale and design of a cluster-randomized pragmatic trial aimed at improving use of guideline directed medical therapy in outpatients with heart failure: PRagmatic trial of messaging to providers about treatment of heart failure (PROMPT-HF)American Heart Journal.  244:107-115. 2022
    2022 Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors with Cognitive ImpairmentJAMA Network Open.  5:E2145319. 2022
    2021 Hypertension in Women Across the LifespanCurrent Atherosclerosis Reports.  23. 2021
    2021 Neighborhood Socioeconomic Status and Identification of Patients With CKD Using Electronic Health RecordsAmerican Journal of Kidney Diseases.  78:57-65.e1. 2021
    2021 Neighborhood Socioeconomic Status and Quality of Kidney Care: Data From Electronic Health Records 2021
    2021 Neighborhood Socioeconomic Status, Health Insurance, and CKD Prevalence: Findings From a Large Health Care System 2021
    2021 REVeAL-HF: Design and Rationale of a Pragmatic Randomized Controlled Trial Embedded Within Routine Clinical PracticeJACC: Heart Failure.  9:409-419. 2021
    2021 Predicting patients with false negative SARS-CoV-2 testing at hospital admission: A retrospective multi-center studyPLoS One.  16. 2021
    2021 The association of orthostatic hypotension with ambulatory blood pressure phenotypes in sprintAmerican Journal of Hypertension.  34:511-520. 2021
    2021 The Association of COVID-19 With Acute Kidney Injury Independent of Severity of Illness: A Multicenter Cohort StudyAmerican Journal of Kidney Diseases.  77:490-499.e1. 2021
    2021 Assessment of Acute Kidney Injury and Longitudinal Kidney Function after Hospital Discharge among Patients with and without COVID-19JAMA Network Open.  4. 2021
    2020 Prognostic significance of ambulatory BP monitoring in CKD: A report from the chronic renal insufficiency cohort (cric) studyJournal of the American Society of Nephrology.  31:2609-2621. 2020
    2020 Effects of Intensive Versus Standard Office-Based Hypertension Treatment Strategy on White-Coat Effect and Masked Uncontrolled Hypertension: From the SPRINT ABPM Ancillary StudyHypertension.  76:1090-1096. 2020
    2020 Effect of Intensive Blood Pressure Lowering on the Risk of Atrial FibrillationHypertension.  75:1491-1496. 2020
    2020 Association of 24-hour ambulatory blood pressure patterns with cognitive function and physical functioning in CKDClinical Journal of the American Society of Nephrology.  15:452-464. 2020
    2020 Role of inflammatory biomarkers in the prevalence and incidence of hypertension among HIV-positive participants in the START trialAmerican Journal of Hypertension.  33:43-52. 2020
    2019 Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINTJournal of the American Heart Association.  8. 2019
    2018 Race, sex, age, and regional differences in the association of obstructive sleep apnea with atrial fibrillation: Reasons for geographic and racial differences in stroke studyThe Journal of Clinical Sleep Medicine.  14:1485-1493. 2018
    2017 Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With HypertensionCirculation.  136:440-450. 2017
    2017 11-beta dehydrogenase type 2 activity is not reduced in treatment resistant hypertensionAmerican Journal of Hypertension.  30:518-523. 2017
    2017 Distinctive Risk Factors and Phenotype of Younger Patients with Resistant Hypertension: Age is RelevantHypertension.  69:827-835. 2017
    2017 Response to letter to Editor “Lessons learned from the recent history of technologies for non-invasive estimation of aortic blood pressure using transfer functions and pulse wave analysis” by Papaioannou et alJournal of the American Society of Hypertension.  11:321-322. 2017
    2017 Assessment of vascular function in low socioeconomic status preschool children: a pilot studyJournal of the American Society of Hypertension.  11:101-109. 2017
    2017 Advances in understanding the renin-angiotensin-aldosterone system (RAAS) in blood pressure control and recent pivotal trials of RAAS blockade in heart failure and diabetic nephropathyF1000Research.  6. 2017
    2016 BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?Current Cardiology Reports.  18. 2016
    2016 Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients with Resistant HypertensionHypertension.  68:995-1003. 2016
    2016 Gender, race, age, and regional differences in the association of pulse pressure with atrial fibrillation: the Reasons for Geographic and Racial Differences in Stroke studyJournal of the American Society of Hypertension.  10:625-632.e1. 2016
    2016 Urinary sodiumexcretion predicts blood pressure response to spironolactone in patients with resistant hypertension independent of aldosterone statusJournal of Hypertension.  34:1005-1010. 2016
    2015 Role of blood transfusion product type and amount in deep vein thrombosis after cardiac surgeryThrombosis Research: vascular obstruction, hemorrhage and hemostasis.  136:1204-1210. 2015
    2015 Perceived Stress and Atrial Fibrillation: The REasons for Geographic and Racial Differences in Stroke StudyAnnals of Behavioral Medicine.  49:802-808. 2015

    Book

    Year Title Altmetric
    2018 Impact of the SPRINT Trial on Hypertension Management.  Ed. 69.  2018

    Research Overview

  • Hypertension, Cardiovascular Disease, Chronic Kidney Disease, Health Disparities, Digital Health, Clinical Trials
  • Education And Training

  • Doctor of Philosophy in Epidemiology, University of Minnesota-Twin Cities 2021
  • Doctor of Medicine, 2014
  • Full Name

  • Lama Ghazi